Utah Medical Products Inc (UTMD)
68.48
+1.42
(+2.12%)
USD |
NASDAQ |
Apr 19, 16:00
68.48
0.00 (0.00%)
After-Hours: 20:00
Utah Medical Products Gross Profit Margin (Quarterly): 57.55% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.55% |
September 30, 2023 | 58.85% |
June 30, 2023 | 60.15% |
March 31, 2023 | 62.64% |
December 31, 2022 | 61.35% |
September 30, 2022 | 63.19% |
June 30, 2022 | 60.70% |
March 31, 2022 | 61.13% |
December 31, 2021 | 62.82% |
September 30, 2021 | 64.21% |
June 30, 2021 | 61.77% |
March 31, 2021 | 63.36% |
December 31, 2020 | 60.49% |
September 30, 2020 | 62.00% |
June 30, 2020 | 56.33% |
March 31, 2020 | 62.70% |
December 31, 2019 | 66.05% |
September 30, 2019 | 59.06% |
June 30, 2019 | 63.31% |
March 31, 2019 | 63.11% |
December 31, 2018 | 62.59% |
September 30, 2018 | 60.58% |
June 30, 2018 | 63.69% |
March 31, 2018 | 63.58% |
December 31, 2017 | 63.43% |
Date | Value |
---|---|
September 30, 2017 | 64.16% |
June 30, 2017 | 63.65% |
March 31, 2017 | 63.70% |
December 31, 2016 | 61.46% |
September 30, 2016 | 59.81% |
June 30, 2016 | 59.60% |
March 31, 2016 | 60.41% |
December 31, 2015 | 61.52% |
September 30, 2015 | 61.13% |
June 30, 2015 | 58.66% |
March 31, 2015 | 59.73% |
December 31, 2014 | 62.36% |
September 30, 2014 | 57.81% |
June 30, 2014 | 60.52% |
March 31, 2014 | 61.57% |
December 31, 2013 | 59.43% |
September 30, 2013 | 59.30% |
June 30, 2013 | 60.47% |
March 31, 2013 | 60.55% |
December 31, 2012 | 61.23% |
September 30, 2012 | 61.75% |
June 30, 2012 | 60.56% |
March 31, 2012 | 60.13% |
December 31, 2011 | 59.69% |
September 30, 2011 | 60.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
56.33%
Minimum
Jun 2020
66.05%
Maximum
Dec 2019
61.46%
Average
61.77%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 10.78% |
Xtant Medical Holdings Inc | 60.97% |
Asensus Surgical Inc | 21.47% |
Catheter Precision Inc | 94.53% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 13.72% |
Return on Assets | 12.82% |
Return on Invested Capital | 13.72% |
Profit Margin (Quarterly) | 34.75% |
Operating Margin (Quarterly) | 31.98% |
Return on Net Operating Assets | 17.29% |